Neuroone Medical Technologies (NMTC) Non-Current Assets (2011 - 2026)

Neuroone Medical Technologies has disclosed Non-Current Assets across 12 years of filings, most recently posting $461160.0 for Q1 2026.

• Quarterly Non-Current Assets fell 34.36% year-over-year to $461160.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.2 million (down 28.57% YoY) and the FY2025 annual result came in at $559363.0, down 24.31% from the prior year.
• Non-Current Assets declined to $461160.0 in Q1 2026, from $510525.0 in the prior quarter.
• Across five years, Non-Current Assets topped out at $879353.0 in Q2 2023 and bottomed at $461160.0 in Q1 2026.
• The 5-year median for Non-Current Assets is $693233.0 (2022), against an average of $693284.4.
• Year-over-year, Non-Current Assets jumped 37.04% in 2023 and tumbled 34.77% in 2025.
• Neuroone Medical Technologies' Non-Current Assets stood at $693233.0 in 2022, then increased by 5.21% to $729371.0 in 2023, then advanced by 7.31% to $782665.0 in 2024, then tumbled by 34.77% to $510525.0 in 2025, then dropped by 9.67% to $461160.0 in 2026.
• According to Business Quant data, Non-Current Assets over the past three periods registered $461160.0, $510525.0, and $559363.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.